Charlotte Kervran
Biographic Data
| ID | 5513671 |
|---|---|
| NAME | Charlotte Kervran |
| GIVEN NAMES | Charlotte |
| FAMILY NAME | Kervran |
| SIGNATURE | KERVRAN C |
| AFFILIATIONS | Addiction Team, SANPSY, CNRS UMR 6033 Bordeaux France |
| ORCID | 0000-0003-0108-1079 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Enablers and barriers to smoking cessation counselling
Medications for Opioid Use Disorder in People Who Inject Substances
BACKGROUND: Opioid Use Disorder (OUD) often provokes dramatic consequences in terms of increased morbi-mortality. Two medications have mainly been worldwide used for OUD (MOUD), buprenorphine and methadone. Recently, however, some reports have highlighted the use of Morphine Sulfate (MS) mainly obtained without a prescription but used as MOUD by opioid users and especially People Who Inject Substances (PWIS). We propose to characterize the preval…
Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs
AIMS: The primary aim of this study was to evaluate the impact of drug consumption rooms (DCRs) in France on injection equipment-sharing, while the secondary aims focused upon their impact on access to hepatitis C virus (HCV) testing and opioid agonist treatment (OAT). DESIGN: The COhort to identify Structural and INdividual factors associated with drug USe (COSINUS cohort) was a 12-month longitudinal study of 665 people who inject drugs (PWID), …
Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France
BACKGROUND: The effectiveness of drug consumption rooms (DCRs) for people who inject drugs (PWID) has been demonstrated for HIV and hepatitis C virus risk practices, and access to care for substance use disorders. However, data on other health-related complications are scarce. Using data from the French COSINUS cohort, we investigated the impact of DCR exposure on non-fatal overdoses, abscesses and emergency department (ED) visits, all in the pre…
Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach
No prominent works on this page.
Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach
Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France
BACKGROUND: The effectiveness of drug consumption rooms (DCRs) for people who inject drugs (PWID) has been demonstrated for HIV and hepatitis C virus risk practices, and access to care for substance use disorders. However, data on other health-related complications are scarce. Using data from the French COSINUS cohort, we investigated the impact of DCR exposure on non-fatal overdoses, abscesses and emergency department (ED) visits, all in the pre…
Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs
AIMS: The primary aim of this study was to evaluate the impact of drug consumption rooms (DCRs) in France on injection equipment-sharing, while the secondary aims focused upon their impact on access to hepatitis C virus (HCV) testing and opioid agonist treatment (OAT). DESIGN: The COhort to identify Structural and INdividual factors associated with drug USe (COSINUS cohort) was a 12-month longitudinal study of 665 people who inject drugs (PWID), …
Medications for Opioid Use Disorder in People Who Inject Substances
BACKGROUND: Opioid Use Disorder (OUD) often provokes dramatic consequences in terms of increased morbi-mortality. Two medications have mainly been worldwide used for OUD (MOUD), buprenorphine and methadone. Recently, however, some reports have highlighted the use of Morphine Sulfate (MS) mainly obtained without a prescription but used as MOUD by opioid users and especially People Who Inject Substances (PWIS). We propose to characterize the preval…
Enablers and barriers to smoking cessation counselling
Medicine (4 works) · Opioid Use Disorder Treatment (4 works) · Psychiatry (4 works) · Cohort (3 works) · HIV, Drug Use, Sexual Risk (3 works) · Internal Medicine (3 works) · Addiction (2 works) · Cohort study (2 works) · Craving (2 works) · Drug (2 works)